http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
-
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
-
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
-
Spear Bio partners with Bio-Techne to distribute immunoassay technology
-
Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
-
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
-
Bio-Techne technology used in FDA-approved gene therapy ZEVASKYN
-
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
-
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
-
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
-
Bio-Techne to Present at Investor Conferences
-
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
-
Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
-
Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
-
Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
-
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
-
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
-
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
-
Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
-
Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
-
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
-
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
-
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
-
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
-
Bio-Techne to Present at Investor Conferences
-
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
-
Bio-Techne (TECH) Announces Release of GMP TcBuster Non-Viral Genome Engineering System
-
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
-
Bio-Techne (TECH) Appoints Amy E. Herr to its Board
-
Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
-
Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results
-
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
-
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
-
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
-
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
-
Bio-Techne (TECH) Successful On Second Claim Of Reverse Engineering By Miltenyi Biotec
-
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
-
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
-
Bio-Techne (TECH) enters co-marketing and co-promotion agreement with Waters Corporation
-
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
-
ScaleReady awards a G-Rex® Grant to Moonlight Bio
-
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
-
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
-
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
-
Bio-Techne (TECH) Enters partnership with Leader Life Sciences
-
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
-
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
-
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
-
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
-
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
